627 POSTER UFT/LV combined with oxaliplatin (TEGAFOX) or with irinotecan (TEGAFIRI) as first-line treatment for metastatic colorectal cancer patients (pts). results of a randomized phase II I.T.M.O. study

首页> 外文期刊>European Journal of Cancer Supplements >627 POSTER UFT/LV combined with oxaliplatin (TEGAFOX) or with irinotecan (TEGAFIRI) as first-line treatment for metastatic colorectal cancer patients (pts). results of a randomized phase II I.T.M.O. study

【24h】

627 POSTER UFT/LV combined with oxaliplatin (TEGAFOX) or with irinotecan (TEGAFIRI) as first-line treatment for metastatic colorectal cancer patients (pts). results of a randomized phase II I.T.M.O. study

机译：627 POSTER UFT / LV联合奥沙利铂（TEGAFOX）或伊立替康（TEGAFIRI）作为转移性结直肠癌患者（pts）的一线治疗。 I.T.M.O随机第二阶段的结果研究

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2005年第2期|共1页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Uracil|[sol]|ftorafur|[sol]|leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study [J] . E Bajetta, M Di Bartolomeo, R Buzzoni, British Journal of Cancer . 2007,第3期

机译：尿嘧啶| [sol] |氟呋喃| [sol] |亚叶酸钙联合伊立替康（TEGAFIRI）或奥沙利铂（TEGAFOX）作为转移性结直肠癌患者的一线治疗：随机II期研究结果
2. |[lsquo]|A phase II study of oral uracil|[sol]|ftorafur (UFT|[reg]|) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancer|[rsquo]| [J] . J Bennouna, H Perrier, B Paillot, British Journal of Cancer . 2006,第1期

机译：| [lsquo | II口服尿嘧啶| [sol] |氟尿酸（UFT | [reg] |）加亚叶酸钙联合奥沙利铂（TEGAFOX）作为转移性结直肠癌患者的一线治疗的II期研究|
3. A randomized phase II trial evaluating safety and efficacy of an experimental chemotherapy regimen (irinotecan + oxaliplatin, IRINOX) and two standard arms (LV5–FU2 + irinotecan or LV5–FU2 + oxaliplatin) in first-line metastatic colorectal cancer: a study of the Digestive Group of the Fédération Nationale des Centres de Lutte Contre le Cancer [J] . Y. Bécouarn1 P. Senesse2 S. Thézenas2 E. Boucher3 A. Adenis4 L. Cany5 J. H. Jacob6 F. Cvitkovic7 C. Montoto-Grillot8 and M. Ychou2 Annals of Oncology . 2007,第12期

机译：一项II期随机试验，评估一线转移性结直肠癌的实验性化疗方案（伊立替康+奥沙利铂，IRINOX）和两个标准组（LV5-FU2 +伊立替康或LV5-FU2 +奥沙利铂）的安全性和有效性：中央国家癌症中心消化小组
4. Phase I/II clinical trials on the effect of weekly paclitaxel (wPTX) and wPTX containing combination regimens for advanced and metastatic gastric cancer -ECRIN group studies [C] . Sakamoto J, Kodera Y, Kobayashi M, International Gastric Cancer Congress . 2009

机译：I / II期临床试验关于每周紫杉醇（WPTX）和WPTX含有晚期和转移性胃癌组合方案的临床试验 - 分泌组研究
5. Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study [O] . E Bajetta, M Di Bartolomeo, R Buzzoni, 2007

机译：尿嘧啶/氟尿嘧啶/亚叶酸钙联合伊立替康（TEGAFIRI）或奥沙利铂（TEGAFOX）作为转移性结直肠癌患者的一线治疗：随机II期研究结果
6. Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised phase II study [O] . Bajetta, E, Di Bartolomeo, M, Buzzoni, R, 2007

机译：尿嘧啶/氟尿嘧啶/亚叶酸钙联合伊立替康（TEGAFIRI）或奥沙利铂（TEGAFOX）作为转移性结直肠癌患者的一线治疗：随机II期研究结果

627 POSTER UFT/LV combined with oxaliplatin (TEGAFOX) or with irinotecan (TEGAFIRI) as first-line treatment for metastatic colorectal cancer patients (pts). results of a randomized phase II I.T.M.O. study

著录项

相似文献

相关主题

期刊订阅